Advertisement
Loading...

Abeona Therapeutics Inc.

ABEO•NASDAQ
Healthcare
Biotechnology
$5.49
$-0.11(-1.96%)
U.S. Market opens in 0h 27m

Abeona Therapeutics Inc. (ABEO) Stock Overview

Explore Abeona Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap312.9M
P/E Ratio4.74
EPS (TTM)$0.95
ROE0.41%
Fundamental Analysis

AI Price Forecasts

1 Month$4.93
3 Months$4.53
1 Year Target$4.94

ABEO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Abeona Therapeutics Inc. (ABEO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.94.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 4.74 and a market capitalization of 312.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.96%
5-Day Change
-5.51%
1-Month Change
1.67%
3-Month Change
9.58%
6-Month Change
23.37%
Year-to-Date (YTD) Change
4.17%
1-Year Change
-5.18%
3-Year Change
78.25%
5-Year Change
-83.85%
All-Time (Max) Change
-100.00%

Contact Information

https://www.abeonatherapeutics.com
646 813 4701
1330 Avenue of the Americas, Cleveland, NY, 10019

Company Facts

136 Employees
IPO DateSep 19, 1980
CountryUS
Actively Trading

Frequently Asked Questions